Pharmacokinetic/Pharmacodynamic modeling of abexinostat-induced thrombocytopenia across different patient populations: application for the determination of the maximum tolerated doses in both lymphoma and solid tumour patients
Crossref DOI link: https://doi.org/10.1007/s10637-014-0118-1
Published Online: 2014-05-31
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chalret du Rieu, Quentin
Fouliard, Sylvain
White-Koning, Mélanie
Kloos, Ioana
Chatelut, Etienne
Chenel, Marylore
Text and Data Mining valid from 2014-05-31
Version of Record valid from 2014-05-31
Article History
Received: 27 February 2014
Accepted: 20 May 2014
First Online: 31 May 2014